Document ID: chunk:federal_register_of_legislation:F2020C00271:reg:11b:p2
Version: federal_register_of_legislation:F2020C00271
Segment Type: reg
Provision Reference: reg 11B (pt 2/3)
Character Range: 11447–14143

has been the subject of an investigation by the Chief Executive Medicare, and if so, the status of the investigation.
 (8) Information relating to a service or to the supply of a pharmaceutical benefit or other goods may be provided if:
 (a) a health practitioner who is the subject of a complaint or investigation mentioned in subsection (2), (3) or (5):
 (i) provided the service or supplied the pharmaceutical benefit or other goods; or
 (ii) supervised the provision of the service or the supply of the pharmaceutical benefit or other goods; or
 (iii) requested the service or the supply of the pharmaceutical benefit or other goods; or
 (iv) claimed or received payment of fees in relation to the service or the supply of the pharmaceutical benefit or other goods; or
 (v) in the case of a service—was the assignee under an assignment or agreement, made or entered into in accordance with section 20A of the Health Insurance Act 1973, in relation to the medicare benefit in respect of the service; and
 (b) the Chief Executive Medicare reasonably believes that the service or the supply of the pharmaceutical benefit or other goods is relevant to the complaint or investigation.
 (9) The information mentioned in subsection (11) relating to a person may be provided if the person has made a complaint mentioned in subsection (2) or (3).
 (10) The information mentioned in subsection (11) relating to a person may also be provided if:
 (a) the person has received a service or been supplied a pharmaceutical benefit or other goods; and
 (b) a health practitioner who is the subject of a complaint or investigation mentioned in subsection (2), (3) or (5):
 (i) provided the service or supplied the pharmaceutical benefit or other goods; or
 (ii) supervised the provision of the service or the supply of the pharmaceutical benefit or other goods; or
 (iii) requested the service or the supply of the pharmaceutical benefit or other goods; or
 (iv) claimed or received payment of fees in relation to the service or the supply of the pharmaceutical benefit or other goods; or
 (v) in the case of a service—was the assignee under an assignment or agreement, made or entered into in accordance with section 20A of the Health Insurance Act 1973, in relation to the medicare benefit in respect of the service; and
 (c) the Chief Executive Medicare reasonably believes that the service or the supply of the pharmaceutical benefit or other goods is relevant to the complaint or investigation.
 (11) For the purposes of subsections (9) and (10), the information relating to the person is the following:
 (a) name;
 (b) contact information;
 (c) sex;
 (d) date of birth;
 (e) medicare number;
 (f) if the